Aldeyra Therapeutics, Inc.
ALDX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001341235
No open-market purchases or sales by Aldeyra Therapeutics, Inc. insiders were filed in the last 90 days; 107 institutions reported holding it in 13F filings for Q2 2026, worth $77.7M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Aldeyra Therapeutics, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 89 | 1 | 96 | +8 |
| Shares | 37.0M | 807 | 34.2M | −2.78M (−7.5%) |
| Value | $197.4M | $4.31K | $237.9M | +$40.5M (+20.5%) |
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (18)
Institutions that held Aldeyra Therapeutics, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 79,092 | $550.0K | 0.01% |
| Jane Street Group, LLC | 63,182 | $439.7K | 0.00% |
| Natixis | 44,258 | $308.0K | 0.00% |
| Balyasny Asset Management LLC | 31,120 | $216.6K | 0.00% |
| Two Sigma Securities, LLC | 22,387 | $155.8K | 0.02% |
| Lighthouse Investment Partners, LLC | 21,873 | $152.2K | 0.03% |
| Mirabella Financial Services LLP | 20,858 | $145.2K | 0.01% |
| Man Group plc | 19,967 | $139.0K | 0.00% |
| Laidlaw Wealth Management LLC | 18,000 | $125.3K | 0.03% |
| Boothbay Fund Management, LLC | 13,525 | $94.1K | 0.00% |
| American Century Companies Inc | 13,169 | $91.7K | 0.00% |
| Fox Run Management, L.L.C. | 12,682 | $88.3K | 0.04% |
| Magnus Financial Group LLC | 10,370 | $72.2K | 0.01% |
| Vontobel Holding Ltd. | 10,059 | $70.0K | 0.00% |
| Joseph P. Lucia & Associates, LLC | 12,000 | $62.3K | 0.05% |
| Dorsey Wright & Associates | 3,580 | $24.9K | 0.01% |
| Parallax Volatility Advisers, L.P. | 152 | $1.06K | 0.00% |
| Belpointe Asset Management LLC | 50 | $348 | 0.00% |
Sold out (10)
Institutions that held Aldeyra Therapeutics, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Cubist Systematic Strategies, LLC | 116,285 | $621.0K |
| New York Life Investments Alternatives | 85,091 | $454.0K |
| Graham Capital Management, L.P. | 41,590 | $222.0K |
| ExodusPoint Capital Management, LP | 33,685 | $180.0K |
| CSS LLC | 26,828 | $143.0K |
| Curi Capital | 21,500 | $115.0K |
| Virtu Financial LLC | 18,573 | $99.0K |
| Kestra Advisory Services, LLC | 17,138 | $92.0K |
| Alpine Global Management, LLC | 12,025 | $64.0K |
| Tower Research Capital LLC (TRC) | 6,754 | $36.0K |
Not filed for Q4 2022 yet (1)
Institutions that held Aldeyra Therapeutics, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Jefferies Group LLC | 807 | $4.31K |